[1]
Bashir, M. 2020. CONCORDANCE BETWEEN SERUM AND TISSUE EGFR MUTATIONS IN PATIENTS WITH ADENOCARCINOMA LUNG. JMS SKIMS. 23, Suppl 1 (Dec. 2020). DOI:https://doi.org/https://doi.org/10.33883/jms.v23iSuppl%201.560.